41 – 50 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
(
- Contribution to journal › Article
-
Mark
The coagulation system and its function in early immune defense.
(
- Contribution to journal › Article
-
Mark
Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories
(
- Contribution to journal › Article
- 2013
-
Mark
Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
(
- Contribution to journal › Article
-
Mark
Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
Age-and sex-specific seasonal variation of venous thromboembolism in patients with and without family history: a nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
Old genes and new genes: The evolution of the kallikrein locus.
(
- Contribution to journal › Scientific review
-
Mark
Antimicrobial activity of fibrinogen and fibrinogen-derived peptides - a novel link between coagulation and innate immunity.
(
- Contribution to journal › Article
-
Mark
Anti-inflammatory, anti-coagulant, anti-biotic?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation
(
- Contribution to journal › Article